## NDSN: Nordson Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 2.3% below STRENGTH zone (3.0-6.0%); PEG 1.74 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($226.67)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Is Nordson Stock Underperforming the S&P 500?**
- Source: Markets Financial Content | 20251215T062700 | Bullish | Relevance: 100%
- Nordson Corporation (NDSN), a large-cap company in the specialty industrial machinery industry, has shown mixed stock performance. While it has outperformed the S&P 500 over the past three months with a 5.5% gain, it has underperformed over six months and the past 52 weeks. Analysts maintain a "Moderate Buy" rating for NDSN, with a target price suggesting a potential 13.4% upside.

**2. Nordson Corporation (NASDAQ:NDSN) Q4 2025 Earnings Call Transcript**
- Source: Insider Monkey | 20251213T130907 | Somewhat-Bullish | Relevance: 100%
- Nordson Corporation (NASDAQ: NDSN) reported strong Q4 and fiscal year 2025 results, with adjusted EPS up 9% and record EBITDA of $256 million for the quarter, and record sales of $2.8 billion for the full year. The company emphasized the success of its Ascend Strategy, achieving a 2025 EBITDA goal of $900 million, and provided optimistic guidance for fiscal 2026, anticipating sales growth between 1% and 6% and adjusted EPS growth of 6% to 12%. Management noted stabilization in industrial and polymer processing markets, strong medical segment growth, and continued momentum in semiconductor applications within their Advanced Technology Solutions segment.

**3. Nordson (NASDAQ:NDSN) Upgraded by Vertical Research to "Buy" Rating**
- Source: MarketBeat | 20251215T145535 | Bullish | Relevance: 100%
- Vertical Research has upgraded Nordson (NASDAQ:NDSN) to a "Buy" rating from "Hold," setting a price target of $270.00, indicating a potential upside of 13.35%. This comes as Nordson reported stronger-than-expected quarterly EPS of $3.03 and provided an optimistic FY2026 EPS guidance of $10.80–$11.50, despite recent insider share sales totaling approximately $3.19 million. The company currently holds a consensus "Moderate Buy" rating among analysts with an average target price of $268.00.

**4. Here's Why You Should Retain Ingersoll Rand in Your Portfolio**
- Source: TradingView — Track All Markets | 20251215T160758 | Somewhat-Bullish | Relevance: 61%
- Ingersoll Rand (IR) is experiencing increased orders across its industrial and precision science technologies segments, driven by both organic growth and strategic acquisitions. Despite facing challenges like rising operating costs and a leveraged balance sheet, the company's strong free cash flow supports shareholder-friendly activities. The article suggests retaining IR in a portfolio due to its growth drivers, while also mentioning other highly-rated stocks like Helios Technologies, Flowserve Corporation, and Nordson Corporation as better-ranked alternatives.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | DA Davidson | $290 | $285 | +2% |
| 2025-12-12 | Baird | $275 | $252 | +9% |
| 2025-12-11 | DA Davidson | $285 | $285 | 0% |
| 2025-12-11 | Keybanc | $295 | $250 | +18% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | DA Davidson | main | Buy |
| 2025-12-12 | Baird | main | Neutral |
| 2025-12-11 | DA Davidson | main | Buy |
| 2025-12-11 | Keybanc | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($1.77M) |
| Sells | 12 ($3.60M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 10.8% (-2.1%)
- Blackrock Inc.: 6.8% (-0.3%)
- State Street Corpora: 5.1% (-3.2%)
- Kayne Anderson Rudni: 4.4% (-2.4%)
- Geode Capital Manage: 2.7% (+1.3%)

### Key Risks

1. Insider selling cluster: $3.6M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +10%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +4.6% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.74 elevated, pricing in significant growth expectations. Forward P/E 19.9x stretched relative to 8% growth. Quality metrics strong (margin 17%). Analyst sentiment positive (3 raises, avg +10%). Insider selling cluster ($3.6M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 8 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.4B |
| Beta | 1.02 |
| 52W Range | $165.03 - $251.47 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.74 |
| Forward P/E | 19.9 |
| Current P/E | 21.4 |
| YoY Growth | 7.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -2.2% to 2.3% (+4.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.7pp (needs >3.0% for momentum thesis). MRS_5 at 2.5% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56. OFD pattern: +DBH (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.31% (CS: 52) | Neutral |
| RSI_14 | 56.2 | Neutral |
| MACD Histogram | -0.05 | Bearish |
| vs SMA20 | 1.014x | Above |
| vs SMA50 | 1.017x | Above |
| vs SMA200 | 1.101x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $237.79
- **Stop Loss:** $226.67 (4.7% risk)
- **Target:** $248.91 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 107
- **Position Value:** $25,443.53
- **Portfolio %:** 25.44%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.93 | $3.03 | +3.4% |
| 2025Q3 | $2.64 | $2.73 | +3.5% |
| 2025Q2 | $2.36 | $2.42 | +2.6% |
| 2025Q1 | $2.08 | $2.06 | -0.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*